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Abstract
Background: Several studies have indicated that obsessive-compulsive disorder (OCD) is a common comorbidity in
patients with psychotic disorders, but there is sparse knowledge about the relationship between symptoms of OCD
and psychotic symptoms. Metacognitions which guides thinking and coping is theorized to be a transdiagnostic
component central for development and maintenance of psychological disorders, OCD and psychosis included. The
aim of the study was therefore to explore how symptoms of OCD and metacognitions relate to symptoms of
psychosis. Our main hypotheses were that metacognitions would be significantly related to all symptoms of
psychological distress, and that there is considerable overlap between symptoms of psychosis and OCD.
Methods: Community controls (N = 194) completed an internet survey measuring levels of paranoid ideation,
predisposition to hallucinations, symptoms of OCD, depression, anxiety, and metacognitions. Correlations and
hierarchical multiple linear regression analyses were used to unveil the relationship between symptoms and beliefs.
Results: Symptoms of OCD showed a strong positive correlation with symptoms of psychosis, and the relationships
were still significant after controlling for symptoms of anxiety and depression. Metacognitions also showed strong
positive correlations with all symptom measures. Metacognition and OCD-symptoms accounted for 53.8% of the
variance in paranoid ideation and 43.8% of predisposition to hallucinations. There was a large overlap between
symptoms of psychosis, OCD-symptoms, and metacognitions (30.2–37.3%).
Conclusions: In general, the results suggest considerable overlap between paranoid ideation, predisposition to
hallucinations, and OCD and metacognitive beliefs in a non-clinical sample. Further experimental- and clinical
studies are needed in order to explore metacognitive models of OCD and psychosis.
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Background
Several studies indicate that obsessive-compulsive disorder
(OCD) is a common comorbid disorder for patients with
psychotic disorders [1, 2]. In a recent Norwegian study, an
OCD prevalence rate of 10.6% was found in patients with
first episode psychosis [3]. Still, little is known about the
relationship between OCD-symptoms and symptoms of
psychosis. Existing research indicates that psychosis with
comorbid OCD is associated with a more severe clinical
presentation and lower functioning, more depressive
symptoms, higher rates of suicidality, although OCD does
not seem to affect levels of psychotic symptoms [2–7].
OCD has also been reported to be a risk factor for later de-
velopment of psychosis [8].
Psychiatric disorders often have overlapping symptoms,
which suggests that shared psychopathological processes
may be involved in manifestations of symptoms [9]. This
also is the case of OCD and psychosis. Both disorders
involve intrusions that are difficult to control [10], and dif-
ferentiating between delusions and obsessions can some-
times be difficult [11]. There is also a considerable overlap
between OCD and schizophrenia in terms of course of the
disorder and debut age as well as pathophysiological un-
derpinnings, which may explain the increased coexistence
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of OCD-symptoms and psychotic symptoms [1]. OCD
could have a particularly strong connection with schizo-
typal and psychotic symptoms, as they both are character-
ized by magical or bizarre thinking patterns [12]. There is
also reported a higher than expected prevalence of
psychotic-like symptoms, in form of hallucinations,
delusions, and/or thought disorder in patients with OCD
[13, 14].
Metacognitions have been proposed to be a possible
link between psychosis and OCD [15]. Metacognitions
refer to beliefs, processes and strategies that monitor,
controls or interpret thinking [16]. Metacognitions have
been reported to be associated with symptoms of a wide
range of psychological disorders, which suggests it may
represent a vulnerability to multiple forms of psycho-
pathology [17]. Metacognitive beliefs may also play a
role in the development of psychotic symptoms as sug-
gested by the self-regulatory executive function (S-REF)
model [18, 19]. This model suggests that vulnerability to
psychological dysfunction is linked with a cognitive at-
tentional syndrome (CAS) characterized by heightened
self-focused attention, ruminative worry-based process-
ing, and dysfunctional metacognitive beliefs. The S-REF
model indicates that as with worry, paranoia may be
conceptualized as a strategy more frequently used by
people with positive metacognitive beliefs about their
paranoia (e.g. thinking of paranoia as a survival strategy).
When applying metacognitive principles to paranoia it is
theorized that distress may develop when cognitive dis-
sonance is caused by the activation of such positive and
negative metacognitive beliefs (e.g. paranoia is uncon-
trollable) [20]. A similar model of auditory hallucina-
tions has also been developed in which hallucinatory
experiences are conceptualized as cognitive intrusions
mediated by dysfunctional metacognitive beliefs [21].
In support of the metacognitive model of psychotic
symptoms it has been found that dysfunctional metacog-
nitive beliefs are often found in psychotic patients [22],
first episode psychosis [23] and psychosis-prone groups
[24]. Metacognitive beliefs have been found to be associ-
ated with severity of psychotic symptoms [25, 26],
although this is not been constantly reported [27]. In a
recent meta-analysis [28], it was found that patients with
psychosis reported higher scores on all subscales of the
Metacognition Questionnaire (MCQ) [29] compared to
non-psychiatric controls. It was also found that patients
with psychosis reported higher scores on the positive be-
liefs about worry subscale compared to patients with
emotional disorders. Furthermore, higher scores on
MCQ seem to be associated both with emotional and
psychological disturbance in general, as well as with
proneness to psychotic experiences [30], and clinical and
non-clinical paranoia [31, 32]. Although these results
suggest an association between metacognitions and
psychosis, it is important to control for important covar-
iates including anxiety and depression when interpreting
these results. A recent meta-analysis provided a compre-
hensive review of studies that have analyzed the role of
metacognitive beliefs in the proneness to hallucinations
[33]. The study found that metacognitive beliefs were sig-
nificantly associated with hallucination-proneness, with ef-
fect sizes falling in the moderate-to large range.
In order to further explore the relationship between
psychosis and OCD, and metacognition this study set
forth to empirically investigate these relationships in a
community sample. In testing for associations between
OCD and psychosis and predictor variables it is neces-
sary to control for the variance these constructs share
with depression and anxiety because any relationship
may be spurious and due to overlap with depression/
anxiety rather than being specific to symptoms of OCD
and psychosis. To our knowledge, the influence of meta-
cognitions and OCD on the manifestations of psychotic
symptoms has not yet been investigated. This is import-
ant, since the functional relationship between OCD and
psychosis is not well understood. The metacognitive
model has potential transdiagnostic utility, as it empha-
sizes the importance of metacognitions across psychi-
atric symptoms. The main hypotheses were therefore
that metacognition would be significantly related to all
symptoms of psychological distress, and that there is




A community sample of 194 people took part in an
internet survey. They had a mean age of 34.21 (±11.26)
and the majority were female (69.6%). The sample con-
sisted of full-time workers (56.7%) and full-time students
(24.2%). Some of the participants were receiving disabil-
ity pensions or were unemployed (7.7%), 1.0% was
retirees, and 10.3% were in part-time work or studies. A
third (30.9%) of the sample was single. The participants
were invited to take part in the survey by invitations on




The PS [34] is a 20-item scale that measures subclinical
paranoid ideation found in normal individuals. Each
item is scored on a 5-point Likert scale, with total scores
ranging from 20 to 100. Higher scores reflect higher
levels of subclinical paranoia. Subclinical paranoia is
defined as a style of thought manifested by exaggerated
self-referential biases that arise in ordinary, daily behav-
ior and occurs across a wide range of psychopathologies
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[34]. The PS was developed for use in analogue samples
but has also shown to be useful in persons with paranoid
schizophrenia [35]. In the current study the Cronbach’s
alpha was 0.93.
The launay–slade hallucination scale - revised (LSHS-R)
The LSHS-R [36, 37] is a frequently applied 12-item
scale widely used to measure predisposition to hallucina-
tions in healthy individuals. Participants score each item
on a 5-point Likert scale (0 = certainly does not apply;
4 = certainly applies). The scores from each item are
summed to obtain a total score (0–48), with higher
scores indicating a stronger predisposition towards hal-
lucinatory experiences. Cronbach’s alpha in the current
study was 0.85.
Obsessive-compulsive inventory revised (OCI-R)
The OCI-R is an 18-item self-report questionnaire [38].
OCI-R was developed to examine the presence and se-
verity of obsessive-compulsive symptoms on a five point
Likert scale that assess distress associated with various
OCD- symptoms from 0 (not at all) to 4 (extremely).
The total score of the OCI-R provides information about
the OCD severity, but there are also subscales which ad-
dresses the severity of the different subtypes of OCD. In
this study, the sum of the OCI-R was used as a continu-
ous variable in the statistical analyses, and we the rec-
ommended cut-off point of 21 was used to describe
clinical symptoms of OCD in the sample [39]. The OCI-
R has earlier been shown to be a valid and reliable
screening instrument for OCD [38]. A study with a Nor-
wegian sample also found results supporting the validity
of OCI-R [40]. In the current study, the OCI-R showed
adequate psychometric characteristics with a Cronbach’s
alpha of 0.89 for the total score.
Patient health questionnaire 9-item (PHQ-9)
The PHQ-9 contains nine items referring to criteria for
depression [41] and the answers refer to the past two
weeks. The items are scored on a four point Likert scale
from 0 (not at all) to 3 (nearly every day). In this study,
the sum of scores of the PHQ-9 items was used as a
continuous variable for the statistical analysis, and the
recommended cut-off point of 10 to describe clinical
symptoms of depression in the sample [42]. The PHQ-9
has been shown to have good reliability and validity [42].
Cronbach’s alpha in the current study was 0.86.
Generalized anxiety disorder 7-item (GAD-7)
The subjects are asked how often, during the last
2 weeks, they have been bothered by each of the seven
core symptoms of generalized anxiety disorder. The
items are scored on a four point Likert scale from 0 (not
at all) to 3 (nearly every day). In this study the sum of
GAD-7 items were used as a continuous variable for the
statistical analyses, and the recommended cut-off point
of 10 to describe clinical symptoms of anxiety in the
sample. The GAD-7 has been shown to have good reli-
ability and validity [43]. Cronbach’s alpha in the current
study was 0.87.
The metacognition questionnaire (MCQ-30)
The MCQ [44] is a 30-item questionnaire measuring
metacognitions, where higher scores indicates more dys-
functional metacognitions. It consists of five subscales:
cognitive confidence, negative beliefs (about the danger
and uncontrollability of thoughts), beliefs about the need
to control thoughts, positive beliefs about worry, and
cognitive self-consciousness. Cronbach’s alpha in the
current study was 0.93.
Statistics
To explore the relationship between symptom measures
and metacognitions, we used Pearson’s correlations and
partial correlational analysis. We also conducted two
hierarchical regression analyses; metacognitions and
OCD-symptoms were entered in step 1, and age, sex, de-
pressive symptoms and anxiety symptoms were entered
in step 2. The dependent variables used in the regres-
sions were PS and LSHS-R. In order to explore which
dimensions of metacognitions explained the most vari-
ance of psychotic symptoms, we also conducted two
multiple forward regressions entering the MCQ sub-
scales as independent variables.
Results
With regard to symptoms of anxiety, 45.9% of the sam-
ple reported no difficulties, 45.9% reported some diffi-
culties, 7.6% reported to have clear difficulties, and 0.5%
had extreme difficulties. A total of 11.9% scored above
suggested cut-off (10 points) on the GAD-7. With regard
to depressive symptoms, 48.4% reported no difficulties,
42.0% reported some difficulties, 8.0% had clear difficul-
ties, and 1.6% reported severe difficulties. On the PHQ-
9, 23.9% scored above suggested cut-off of 10 points.
With regard to symptoms of OCD, 6.7% scored above
suggested cut-off of 21 points on the OCI-R.
For psychotic symptoms, 6.2% scored above suggested
cut-off (53 points or more) on the Paranoia scale. Cut-
offs scores have been suggested to range from 29 to 32
on LSHS-R and 2.7% scored above 29 and 2.1% scored
above 32. A summary of scores on symptoms measures
and metacognitive beliefs is presented in Table 1.
There were significant gender differences on some of
the symptom measures, as women had higher scores
than men on LSHS-R, PS, OCI-R and PHQ-9. Women
reported higher mean scores on GAD-7 than men
(M[SD] = 5.4 [4.4] vs. 4.3[3.3]), but the difference was
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not significant (p = 0.1).There were no gender differ-
ences on MCQ-30. Age showed a weak negative signifi-
cant correlation with all the symptom measures
(correlation coefficients ranging from −0.19 to −0.27).
The relationship between psychosis, OCD, and
metacognitions
Symptoms of OCD were moderately-strongly correlated
with symptoms of psychosis. The OCI-R – paranoia par-
tial correlation controlling for anxiety and depression
was 0.44 and 0.35 for OCI-R and hallucinations. Meta-
cognitions were significantly correlated with all symptom
measures as hypothesized. Correlations between para-
noia and subscales of MCQ ranged from 0.43 (cognitive
confidence) to 0.62 (need to control thoughts). For
LSHS-R and MCQ the correlations ranged from 0.33
(positive beliefs) to 0.63 (need to control thoughts).
Negative beliefs and need to control thoughts showed
the strongest relationship with all symptom measures.
Strength of correlations dropped somewhat when con-
ducting partial correlations controlling for symptoms of
depression and anxiety. However, all correlations were
still significant except for cognitive confidence and
symptoms of paranoia. A summary of the correlations is
shown in Table 2.
A hierarchical multiple linear regression was calcu-
lated to predict psychotic symptoms (paranoid ideation
and predisposition to hallucinations). In the first step,
both OCI-R (β = 0.339, t = 4.92) and MCQ (β = 0.455,
t = 6.60) showed a significant influence on paranoid
ideation, R2 = 0.54, (F(2193) = 111.00), p < 0.001. In the
second step, OCI-R (β = 0.273, t = 3.80), MCQ
(β = 0.387, t = 5100), and PHQ-9 (β = −0.258, t = −3,44)
showed a significant influence on paranoid ideation,
while GAD-7 (β = −0.098, t = −1.39), age (β = −0.034,
t = −0.68) and sex (β = −0.026, t = −0.53) were non-
significant. Together the second step explained a signifi-
cant proportion of the variance, R2 = 0.57,
(F(6187) = 40.61, p < 0.001). When using paranoia as
the dependent variable; metacognitions and OCD-
symptoms explained 53.8% of the variance in symptoms
of paranoia. Metacognitions explained 10.6%, and OCD-
symptoms explained 5.9% unique variance, while the
overlap between paranoid ideation, OCD-symptoms and
Metacognitions were 37.3%. A forward regression found
that PHQ-9, OCI-R, and the MCQ subscales “positive
beliefs” and “cognitive self-consciousness”, were related
to paranoid ideation.
Another hierarchical multiple linear regression was also
calculated to predict predisposition to hallucinations. In
Table 1 Scores on symptom measures and metacognitive beliefs
N Min Max Range Mean SD
Paranoia scale 194 20 85 20–100 30.62 12.22
LSHS-R 188 0 43 0–48 6.35 7.48
OCI-R 194 0 53 0–72 6.78 7.92
PHQ-9 194 0 23 0–27 5.66 4.63
GAD-7 194 0 21 0–21 5.09 4.10
MCQ 194 30 106 30–120 47.15 13.75
Positive beliefs 6 24 6–24 8.65 2.94
Negative beliefs 6 24 6–24 9.89 3.87
Cogn. confidence 6 22 6–24 9.60 3.70
Need to control 6 23 6–24 8.60 3.55
Cogn. self-consc. 6 24 6–24 10.40 3.64
LSHS-R The Launay–Slade Hallucination Scale - Revised, OCI-R Obsessive
Compulsive Inventory – Revised, PHQ-9 Patient Health Questionnaire-9, GAD-7
Generalized Anxiety Disorder-7, MCQ Metacognitions Questionnaire-30. Six
participants did not answer the LSHS-R, as the participants were able to
terminate the study without completing all questionnaires
Table 2 Correlations and partial correlations between symptom measures and metacognitive beliefs
Paranoia Hallucinations OCD Anxiety Depression
(PS) (LSHS-R) (OCI-R) (GAD-7) (PHQ-9)
LSHS-R 0.56 (0.32)
OCI-R 0.66 (0.44) 0.59 (0.35)
GAD-7 0.47 0.45 0.54
PHQ-9 0.61 0.60 0.62 0.69
MCQ 0.69 (0.50) 0.63 (.41) 0.70 (0.47) 0.61 0.64
Positive beliefs 0.51 (0.38) 0.33 (.15*) 0.49 (0.31) 0.49 0.38
Negative beliefs 0.61 (0.39) 0.53 (.29) 0.64 (0.40) 0.62 0.60
Cogn. Confidence 0.42 (0.14 ns) 0.51 (.27) 0.49 (0.24) 0.36 0.55
Need to control 0.62 (0.41) 0.63 (.44) 0.67 (0.47) 0.51 0.57
Cogn. self-consc. 0.51 (0.39) 0.40 (.24) 0.40 (0.21**) 0.39 0.36
LSHS-R The Launay–Slade Hallucination Scale - Revised, OCI-R Obsessive Compulsive Inventory – Revised, PHQ-9 Patient Health Questionnaire-9, GAD-7 Generalized
Anxiety Disorder-7, MCQ Metacognitions Questionnaire-30. Partial correlations presented in parentheses control for both anxiety and depression
All correlations otherwise specified were significant (p < 0.001)
* p < 0.05, ** p < 0.01
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the first step, both OCI-R (β = 0.30, t = 3.84) and MCQ
(β = 0.42, t = 5.49) showed a significant influence on pre-
disposition to hallucinations (R2 = 0.43, F(2195) = 77.23,
p < 0.001). In the second step, OCI-R (β = 0 .22, t = 2.78),
MCQ (β = 0.34, t = 4.09), PHQ-9 (β = 0.36, t = 4.31), and
GAD-7 (β = −0.17, t = −2.03) showed a significant influ-
ence on predisposition to hallucinations, while age
(β = −0.05, t = 0.87) and sex (β = −0.05, t = 0.89) were
non-significant. Anxiety symptoms were positively corre-
lated with predisposition to hallucinations (r = 0.45).
However, in the regression whilst controlling for OCI-R,
PHQ-9, MCQ, gender, and age, the coefficient was nega-
tive. This surprise finding was not due to multicollinearity
as the VIF (1.1–2.5) and tolerance statistics (0.4–1.0) were
within an acceptable range. This indicates that anxiety
symptoms are a weaker predictor of predisposition to hal-
lucinations than metacognitions, OCD symptoms, and
symptoms of depression. Together the second step
explained a significant proportion of the variance
R2 = 0.48, (F(6181) = 29.22), p < 0.001. Using halluci-
nations as the dependent variable; 43.8% of the vari-
ance was explained by metacognitions and OCD. The
unique contributions of metacognitions were 9.1%,
and OCD-symptoms explained 4.5% unique variance,
while there overlap between predisposition to halluci-
nations, OCD and metacognitions were 30.2%. A for-
ward regression found that PHQ-9, OCI-R and the
MCQ subscale “need for control” were related to pre-
disposition to hallucinations. See Table 3 for a sum-
mary of the regression analyses.
Discussion
The aim of the current study was to explore the role of
obsessive-compulsive symptoms and metacognitions in
psychotic symptoms. The results suggest considerable
overlap between paranoid ideation, predisposition to hal-
lucinations, and OCD and metacognitive beliefs in a
non-clinical sample. Correlational analyses indicated
strong positive correlations between symptoms of psych-
osis, metacognitions and OCD-symptoms. For paranoia,
all subscales of MCQ (except cognitive confidence) were
correlated as well as OCD-symptoms. The same patterns
were found in a study of patients with OCD and schizo-
phrenia, were all subscales of MCQ were related to
schizophrenia except “cognitive confidence” [15]. The
results is also in line with findings from Morrison and
colleagues [45] that positive metacognitive beliefs about
paranoia are associated with a greater severity of para-
noid symptoms.
For predisposition to hallucinations, both OCI-R and
all subscales of MCQ were significant correlated. These
findings are in line with findings from a recent meta-
analysis that indicated that patients with psychosis had
significantly higher scores on all the MCQ-subscales
Table 3 Hierarchical linear regression analysis of factors related to psychotic symptoms
Hallucination Paranoia
Step 1: (adj. R2 = 0.43**) β Sig Step 1: (adj. R2 0.55**) β sig
OCI-R 0.295 <0.001** OCI-R 0.339 <0.001**
MCQ 0.422 <0.001** MCQ 0.455 <0.001**
Step 2: (R2 Change = 0.054*) Step 2: (R2 Change =0.028*)
OCI-R 0.219 .006** OCI-R 0.273 <0.001**
MCQ 0.342 <0.001** MCQ 0.387 <0.001**
Gender −0.048 0.374 Gender −0.026 0.599
Age −0.048 0.388 Age −0.034 0.496
PHQ-9 0.357 <0.001* PHQ-9 0.258 <0.001**
GAD-7 −0.165 0.044* GAD-7 −0.098 0.166
Forward regressions using MCQ subscales
Gender −0.052 0.330 Gender −.016 0.743
Age −0.048 0.382 Age −.033 0.511
PHQ-9 0.363 <0.001** PHQ-9 .339 <0.001**
GAD-7 −0.126 0.109 GAD-7 −.112 0.118
OCI-R 0.202 0.011* OCI-R .338 <0.001**
MCQ need to control 0.345 <0.001** MCQ cogn. Self-consc. .208 <0.001**
MCQ positive beliefs .159 0.013*
* = (p < .05). ** p < .001
OCI-R Obsessive Compulsive Inventory – Revised, PHQ-9 Patient Health Questionnaire-9, GAD-7 Generalized Anxiety Disorder-7, MCQ
Metacognitions Questionnaire-30
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compared with non-psychiatric controls, [28]. This is
also in line with previous findings of a significant correl-
ation between all subscales of MCQ and LSHS-R in non-
clinical sample [46] and in a sample of hallucination-prone
subjects [47]. The findings from the study support the S-
REF model [18, 19], which, although not targeted specific-
ally at explaining processes in psychosis, predicts that meta-
cognitive beliefs are related to the development and
maintenance of emotional disorders [18, 19].
The relationship between predisposition to hallucina-
tions, and metacognitions and OCD-symptoms were still
significant after controlling for symptoms of anxiety and
depression, as well as sex and age. The regression ana-
lysis indicated that metacognitions and OCD-symptoms
were significant related to both predisposition to halluci-
nations and paranoia. In explaining predisposition to
hallucinations, a total of 43.8% was explained by meta-
cognition and OCD, and there was a substantial degree
of overlap between the three constructs (30.2%). For
paranoid ideation, metacognitions and OCD-symptoms
accounted for 53.8% of the variance, and the degree of
overlap between the constructs were 37.3%. In other
words, the results suggest considerable overlap between
psychotic symptoms and symptoms of OCD which may
be related to metacognitive beliefs. Interestingly, symp-
toms of anxiety were significant negatively associated
with predisposition to hallucinations, in the second step
of the regression.
Looking at the subscales of MCQ, the forward regres-
sion analysis indicated that cognitive self-consciousness
and positive beliefs about worry, as well as OCD-
symptoms and depressive symptoms were related to
paranoid ideation. Cognitive self-consciousness have
been argued to be related to an increased attention to
metacognitive beliefs, and thereby may be a trigger of
the onset of psychotic symptoms [48]. Patients with
psychosis have also been found to report higher rates of
positive beliefs about worry, compared to patients at risk
for developing psychosis and healthy controls [49]. For
predisposition to hallucinations, however, the need to
control subscale of MCQ as well as symptoms of OCD
and depression were related to predisposition to halluci-
nations. “Need to control thoughts”, is argued to be cen-
tral in the metacognitive model as it is activated by
worry and rumination and its associated symptoms [50].
In a sample of patients displaying psychotic symptoms,
the “need to control thoughts”-subscale was a consistent
predictor, and remained significant after controlling for
topological characteristics of hallucinations and delu-
sions [51].
As previously mentioned it is important to control for
confounding covariates when interpreting the results.
We therefore included measures of depression- and anx-
iety symptoms, but the significant relationship between
metacognition and symptoms of psychosis and OCD
were still significant after controlling for these variables.
Both symptoms of OCD and metacognitions were re-
lated to level of psychotic symptoms, after controlling
for symptoms of generalized anxiety, depression and
demographic factors. These findings indicate that meta-
cognitions may be related to psychotic symptoms as well
as other emotional disorders. Future studies need to
examine whether the OCD-psychosis relationship is
unique as psychotic symptoms could be elevated in
other patient groups as well. Overall the results supports
previous findings that dysfunctional metacognitive be-
liefs are associated with both symptoms of psychosis
[52], and OCD [53]. The study also indicates that there
is a relationship between metacognitions, OCD and
psychotic symptoms, and that the concepts have a sub-
stantial overlap at subclinical level, even after controlling
for anxiety and depression.
Limitations
Analogue research is commonly used to make inferences
about psychological processes in clinical populations and is
valuable to research [54]. However, the generalizability of
our findings could be compromised by using a non-patient
sample and a cross-sectional design. Furthermore, the study
is correlational and cannot address causality. Longitudinal
studies have, however, indicated that OCD may be a risk
factor for later development of psychosis [8]. With respect
to metacognitions and OCD, one study found that change
in metacognitions accompany improvement in OCD symp-
toms [53], and treatment that focus on metacognitive
mechanisms has led to positive treatment results for OCD
[55, 56]. Exposure therapy for OCD is also associated with
reductions in psychotic and schizotypal symptoms [57].
With respect to metacognitions and psychosis, a study has
indicated that treatment with focus on metacognitions is a
feasible for patients with psychosis [58].
Conclusion
Taken together, these results could be in line with a po-
tential trans-diagnostic utility of the metacognitive
model, as it emphasizes the importance of metacogni-
tions across psychiatric symptoms. The results also sug-
gest a considerable overlap between psychotic symptoms
(paranoia and hallucinations) and symptoms of OCD,
and both of these symptoms were found to be related to
metacognitive beliefs. Further experimental- and treat-
ment studies are needed in order to explore the meta-
cognitive model of OCD and psychosis.
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